{
     "PMID": "20413278",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20100701",
     "LR": "20131121",
     "IS": "0165-1781 (Print) 0165-1781 (Linking)",
     "VI": "182",
     "IP": "2",
     "DP": "2010 May 30",
     "TI": "Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study.",
     "PG": "180-2",
     "LID": "10.1016/j.pscychresns.2009.12.003 [doi]",
     "AB": "We used magnetic resonance imaging to examine the effect of ethyl-eicosapentaenoic acid (E-EPA) on hippocampal T(2) relaxation time in first episode psychosis patients at baseline and after 12 weeks of follow-up. There was an increase in T(2) in the placebo group but not in the E-EPA group, suggesting a neuroprotective effect of E-EPA treatment. In addition, the smaller the increase in T(2), the greater the improvement in negative symptoms.",
     "CI": [
          "Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved."
     ],
     "FAU": [
          "Wood, Stephen J",
          "Cocchi, Luca",
          "Proffitt, Tina-Marie",
          "McConchie, Mirabel",
          "Jackson, Graeme D",
          "Takahashi, Tsutomu",
          "Pantelis, Christos",
          "McGorry, Patrick D",
          "Berger, Gregor E"
     ],
     "AU": [
          "Wood SJ",
          "Cocchi L",
          "Proffitt TM",
          "McConchie M",
          "Jackson GD",
          "Takahashi T",
          "Pantelis C",
          "McGorry PD",
          "Berger GE"
     ],
     "AD": "Melbourne Neuropsychiatry Centre, University of Melbourne, Australia. sjwood@unimelb.edu.au",
     "LA": [
          "eng"
     ],
     "PT": [
          "Clinical Trial",
          "Journal Article",
          "Randomized Controlled Trial",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20100421",
     "PL": "Ireland",
     "TA": "Psychiatry Res",
     "JT": "Psychiatry research",
     "JID": "7911385",
     "RN": [
          "0 (Neuroprotective Agents)",
          "0 (ethyl eicosapentaenoic acid)",
          "AAN7QOV9EA (Eicosapentaenoic Acid)"
     ],
     "SB": "IM",
     "MH": [
          "Adolescent",
          "Analysis of Variance",
          "Double-Blind Method",
          "Eicosapentaenoic Acid/*analogs & derivatives/therapeutic use",
          "Female",
          "Hippocampus/drug effects",
          "Humans",
          "Longitudinal Studies",
          "Male",
          "Neuroprotective Agents/*therapeutic use",
          "Pilot Projects",
          "Psychotic Disorders/*drug therapy/pathology",
          "Statistics as Topic",
          "Young Adult"
     ],
     "EDAT": "2010/04/24 06:00",
     "MHDA": "2010/07/02 06:00",
     "CRDT": [
          "2010/04/24 06:00"
     ],
     "PHST": [
          "2009/10/22 00:00 [received]",
          "2009/12/09 00:00 [revised]",
          "2009/12/10 00:00 [accepted]",
          "2010/04/24 06:00 [entrez]",
          "2010/04/24 06:00 [pubmed]",
          "2010/07/02 06:00 [medline]"
     ],
     "AID": [
          "S0925-4927(09)00300-X [pii]",
          "10.1016/j.pscychresns.2009.12.003 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Psychiatry Res. 2010 May 30;182(2):180-2. doi: 10.1016/j.pscychresns.2009.12.003. Epub 2010 Apr 21.",
     "term": "hippocampus"
}